RO-4383596

N/A

Report date: 2022/06/14 20:00:40

NME

Base Information

Drug NameRO-4383596

Drug Alias NameRO-4383596

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptors antagonistsPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor 2 inhibitors

TargetsPlatelet-derived growth factor receptorFibroblast growth factor receptorsVascular endothelial growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesF. Hoffmann-La Roche Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesF. Hoffmann-La Roche Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A